迎接耐药菌发起的挑战绝非易事，这需要大规模投资研发新的抗菌药，还要为确保药物有效性建立起控制及限制新疗法的医疗制度。
Meeting the challenge of drug-resistant microbes will be difficult. It will require not only major investments in research and development of new anti-microbial drugs, but also a system to control and restrict new treatments, in order to preserve their efficacy.